Showing results (2561-2570 of 3,088) with videos related to
Sort By:
Pageof 309
Drug Safety|July 13, 2017
Medication Errors: A Characterisation of Spontaneously Reported Cases in EudraVigilanceVictoria Newbould, Steven Le Meur, Thomas Goedecke, et al.Drug Safety|April 27, 2018
Safety Experience During Real-World Use of Injectable Artesunate in Public Health Facilities in Ghana and Uganda: Outcomes of a Modified Cohort Event Monitoring Study (CEMISA)H Hilda Ampadu, Alexander N O Dodoo, Samuel Bosomprah, et al.Drug Safety|May 23, 2018
Cohort Study of Psychiatric Adverse Events Following Exposure to Levonorgestrel-Containing Intrauterine Devices in UK General PracticeJim Slattery, Daniel Morales, Luis Pinheiro, et al.Drug Safety|April 13, 2018
Comparison of Data on Serious Adverse Events and Mortality in ClinicalTrials.gov, Corresponding Journal Articles, and FDA Medical Reviews: Cross-Sectional AnalysisRicheek Pradhan, Sonal SinghDrug Safety|June 27, 2019
Androgen Deprivation Therapy for Prostate Cancer and the Risk of Rheumatoid Arthritis: A Population-Based Cohort StudyAdi J Klil-Drori, Christina Santella, Koray Tascilar, et al.Drug Safety|May 22, 2019
Evaluation of Use of Technologies to Facilitate Medical Chart ReviewLoreen Straub, Joshua J Gagne, Judith C Maro, et al.Drug Safety|April 22, 2019
Pharmacovigilance Systems in Arab Countries: Overview of 22 Arab CountriesThamir M Alshammari, Neslihan Mendi, Khalidah A Alenzi, et al.Drug Safety|October 10, 2018
Preventing Future Deaths from Medicines: Responses to Coroners' Concerns in England and WalesRobin E Ferner, Tohfa Ahmad, Zainab Babatunde, et al.Drug Safety|December 20, 1999
A risk-benefit assessment of amifostine in cytoprotectionM Mabro, S Faivre, E RaymondDrug Safety|September 16, 1999
Adverse effects of intravenous immunoglobulin therapyU E Nydegger, M SturzeneggerPageof 309